The long-awaited Covid Moonshot M-Pro pre-clinical inhibitor patent

The MedChemica team announced yesterday on LinkedIN (23/6/25) the 1st patent for their ASAP consortium WO2025125695  with the somewhat cryptic title "CHEMICAL COMPOUNDS ID50000167790940 P. DOC 2025-05-07 FILING NO.:19".

Authors

Publication Details

Journal
Front Matter
Published
2025-06-24
DOI
https://doi.org/10.59350/dy1v0-5g357
Primary Topic
Biomedical Ethics and Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The long-awaited Covid Moonshot M-Pro pre-clinical inhibitor patent

Christopher Southan
Front Matter
Biomedical Ethics and Regulation
article

The long-awaited Covid Moonshot M-Pro pre-clinical inhibitor patent

Christopher Southan
article en

Abstract

The MedChemica team announced yesterday on LinkedIN (23/6/25) the 1st patent for their ASAP consortium WO2025125695  with the somewhat cryptic title "CHEMICAL COMPOUNDS ID50000167790940 P. DOC 2025-05-07 FILING NO.:19".

Front Matter
Openalex Percentile: Top 64%
Biomedical Ethics and Regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The long-awaited Covid Moonshot M-Pro pre-clinical inhibitor patent — Christopher Southan · Front Matter (2025) | TGRS Research Map | TGRS